BofA Securities lifts Hims & Hers Health Inc [HIMS] price estimate. Who else is bullish?

Hims & Hers Health Inc [NYSE: HIMS] jumped around 1.88 points on Friday, while shares priced at $32.22 at the close of the session, up 6.20%.

Compared to the average trading volume of 14.87M shares, HIMS reached a trading volume of 10258617 in the most recent trading day, which is why market watchdogs consider the stock to be active.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

What do top market gurus say about Hims & Hers Health Inc [HIMS]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HIMS shares is $25.23 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HIMS stock is a recommendation set at 2.29. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BofA Securities have made an estimate for Hims & Hers Health Inc shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on November 14, 2024. While these analysts kept the previous recommendation, Needham raised their target price to Buy. The new note on the price target was released on August 22, 2024, representing the official price target for Hims & Hers Health Inc stock. On May 22, 2024, analysts increased their price target for HIMS shares from 16 to 20.

The Average True Range (ATR) for Hims & Hers Health Inc is set at 2.96, with the Price to Sales ratio for HIMS stock in the period of the last 12 months amounting to 6.02. The Price to Book ratio for the last quarter was 15.95, with the Price to Cash per share for the same quarter was set at 1.10. Price to Free Cash Flow for HIMS in the course of the last twelve months was 49.96 with Quick ratio for the last quarter at 1.82.

How has HIMS stock performed recently?

Hims & Hers Health Inc [HIMS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 33.42. With this latest performance, HIMS shares gained by 69.22% in over the last four-week period, additionally plugging by 65.91% over the last 6 months – not to mention a rise of 269.92% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HIMS stock in for the last two-week period is set at 66.63, with the RSI for the last a single of trading hit 70.08, and the three-weeks RSI is set at 64.64 for Hims & Hers Health Inc [HIMS]. The present Moving Average for the last 50 days of trading for this stock 21.73, while it was recorded at 29.98 for the last single week of trading, and 17.85 for the last 200 days.

Hims & Hers Health Inc [HIMS]: Deeper insight into the fundamentals

Hims & Hers Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.82 and a Current Ratio set at 2.14.

Earnings analysis for Hims & Hers Health Inc [HIMS]

With the latest financial reports released by the company, Hims & Hers Health Inc posted 0.05/share EPS, while the average EPS was predicted by analysts to be reported at 0.06/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HIMS.

Insider trade positions for Hims & Hers Health Inc [HIMS]

There are presently around $66.12%, or 74.62%% of HIMS stock, in the hands of institutional investors. The top three institutional holders of HIMS stocks are: VANGUARD GROUP INC with ownership of 16.47 million shares, which is approximately 7.7166%. BLACKROCK INC., holding 14.57 million shares of the stock with an approximate value of $$294.25 million in HIMS stocks shares; and BLACKROCK INC., currently with $$121.94 million in HIMS stock with ownership which is approximately 2.8294%.

Most Popular